Warby Parker Inc Cl A (WRBY) | |||
---|---|---|---|
12.68 0.38 (3.09%) | 05-03 16:00 | ||
Open: | 12.61 | Pre. Close: | 12.3 |
High: | 12.81 | Low: | 12.4 |
Volume: | 919,067 | Market Cap: | 1,498(M) |
Stock Technical Analysis | |
---|---|
Overall: | |
Target: | Six months: 15.37 One year: 16.45 |
Support: | Support1: 11.66 Support2: 9.70 |
Resistance: | Resistance1: 13.16 Resistance2: 14.08 |
Pivot: | 12.49 |
Moving Averages: | MA(5): 12.23 MA(20): 12.74 MA(100): 13.09 MA(250): 12.71 |
MACD: | MACD(12,26): -0.16 Signal(12,26,9): -0.12 |
%K %D: | %K(14,3): 33.93 %D(3): 23.04 |
RSI: | RSI(14): 50.06 |
52-Week: | High: 16.49 Low: 9.83 Change(%): 9.2 |
Average Vol(K): | 3-Month: 1276 10-Days: 1086 |
Prices Prediction (Update @5:00pm) | ||
---|---|---|
If tomorrow: | Open lower | Open higher |
High: | 12.829 - 12.881 | 12.881 - 12.934 |
Low: | 12.275 - 12.328 | 12.328 - 12.382 |
Close: | 12.592 - 12.685 | 12.685 - 12.781 |
Price, MAs and Bollinger Bands |
---|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ WRBY ] has closed below upper band by 40.0%. Bollinger Bands are 20.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
Company profile |
---|
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York. |
Stock chart |
---|
Financial Analysis | |
---|---|
Price to Book Value: | Outperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
Price to Earnings: | Underperform |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
Discounted cash flow: | Underperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
Return on Assets: | Underperform |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
Return on Equity: | Underperform |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
Debt to Equity: | Outperform |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Stock Basics & Statistics | |
---|---|
Exchange: New York Stock Exchange | |
Sector: Healthcare | |
Industry: Medical - Instruments & Supplies | |
Shares Out. (M) | 98.37 |
Shares Float (M) | 70.18 |
% Held by Insiders | 7.15 |
% Held by Institutions | 94.75 |
Shares Short (K) | 9370 |
Shares Short Prior Month (K) | 8920 |
Stock Financials | |
---|---|
EPS | -0.540 |
Book Value (p.s.) | 2.550 |
Profit Margin | -9.44 |
Operating Margin | -11.33 |
Return on Assets (ttm) | -7.5 |
Return on Equity (ttm) | -21.5 |
Qtrly Rev. Growth | 10.5 |
Gross Profit (p.s.) | |
Sales Per Share | 6.809 |
EBITDA (p.s.) | -0.307 |
Qtrly Earnings Growth | |
Operating Cash Flow (M) | 60.99 |
Levered Free Cash Flow (M) | 15.36 |
Stock Valuation | |
---|---|
PE Ratio | -23.48 |
PEG Ratio | |
Price to Book value | 4.97 |
Price to Sales | 1.86 |
Price to Cash Flow | 20.45 |
Stock Dividends | |
---|---|
Dividend | |
Dividend Yield | |
Dividend Growth |